Brief: Ocugen Announces Positive Opinion Of EMA’S Committee For Advanced Therapies For ATMP Classification
03/03/2025 14:53
March 3 (Reuters) - Ocugen Inc OCGN.O: OCUGEN ANNOUNCES POSITIVE OPINION OF EMA’S COMMITTEE FOR ADVANCED THERAPIES FOR ATMP CLASSIFICATION FOR NOVEL MODIFIER GENE THERAPY CANDIDATE OCU410 FOR GEOGRAPHIC ATROPHY AND OCU410ST FOR STARGARDT DISEASE Source text: ID:nGNXC6ymf Further company coverage: OCGN.O (Reuters.Briefs@thomsonreuters.com)